This inhibition of autophagy/mitophagy by liensinine led to the sensitization of doxorubicin-induced cell death of breast cancer cells via increased dynamin-1-like protein (DNM1L) dephosphorylation and translocation to mitochondria and increased mitochondrial fission. The gene discussed is DNM1L; the disease is breast carcinoma.